SGLT2 inhibitors for patients with type 2 diabetes and CKD: a narrative review
Sodium‐glucose co-transporter 2 (SGLT2) inhibitors have recently emerg ed as an effective means to protect kidney function in people with type 2 diabetes and chronic kidney disease (CKD). In this review, we explore the role of SGLT2 inhibition in these individuals. SGLT2 inhibitors specifically act...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Bioscientifica
2023-08-01
|
| Serija: | Endocrine Connections |
| Teme: | |
| Online pristup: | https://ec.bioscientifica.com/view/journals/ec/12/8/EC-23-0005.xml |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|